CANADA: Mounties Attack Injection Safe Site: Harm Reduction Increases Drug Use, Internal Report Says CDC Daily UpdateImportant note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.

Click here to return to CDC Daily Update main menu





DonateNow




CANADA: Mounties Attack Injection Safe Site: Harm Reduction Increases Drug Use, Internal Report Says

Ottawa Citizen (12.11.06) - Thursday, December 21, 2006
Peter O'Neil, Vancouver Sun


An internal, three-page report by the Royal Canadian Mounted Police (RCMP) alleges Vancouver's supervised drug injection site encourages drug use. The pilot Insite project was established to stem overdoses and HIV transmissions through needle-sharing among injection drug users. Vancouver Sun obtained the RCMP report through the Access to Information Act.

"The RCMP has concerns regarding any initiative that lowers the perceived risks associated with drug use," wrote Staff Sgt. C.D. (Chuck) Doucette, Pacific region coordinator for RCMP's drug and organized crime awareness program. "There is considerable evidence to show that when the perceived risks associated with drug use decrease, there is a corresponding increase in the number of people using drugs."

Drug overdose deaths increased between 2004 and 2005 in Vancouver while decreasing in the rest of the province, said Doucette. And there is "no evidence" that Insite users are entering drug treatment or that public drug use around Insite has decreased, he said.

Peer-reviewed, published scientific studies show Insite clients are indeed entering detoxification programs, and nearby public drug use has decreased, said Dr. Thomas Kerr, a researcher at the B.C. Center for Excellence in HIV/AIDS. The RCMP internal report contains numerous errors and lacks credibility, said Kerr. "I really wish that Chuck Doucette and the RCMP would take a similar position as the Vancouver police department, which is to support a rigorous scientific evaluation of the facility before making comment, and to really leave that type of evaluative activity with qualified scientists," he said.
061221
AD062477


Copyright © 2006 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.